Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · IEX Real-Time Price · USD

43.32

-0.90 (-2.04%)

At close: Apr 24, 2024, 4:00 PM

45.46

+2.14 (4.94%)

After-hours: Apr 24, 2024, 5:59 PM EDT

Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	56.2	33.97	201.2	93.59	40.83	45.47	14.19	12.15
Short-Term Investments	503.66	301.75	133.01	77.79	78.07	118.9	0	0
Cash & Cash Equivalents	559.86	335.73	334.21	171.38	118.89	164.38	14.19	12.15
Cash Growth	66.76%	0.45%	95.01%	44.15%	-27.67%	1058.22%	16.79%	-
Other Current Assets	14.3	9.46	10.51	6.11	4.45	2.31	0.97	0.21
Total Current Assets	574.15	345.18	344.72	177.49	123.34	166.68	15.17	12.37
Property, Plant & Equipment	57.43	4.99	4.72	5.41	6.46	4.23	0.4	0.22
Long-Term Investments	0.47	0.67	1.08	0	0	0	0	0
Other Long-Term Assets	3.3	1.34	0.5	0.54	0.58	0.5	0.03	0.01
Total Long-Term Assets	61.2	6.99	6.3	5.95	7.04	4.73	0.43	0.23
Total Assets	635.35	352.18	351.02	183.45	130.38	171.42	15.6	12.6
Accounts Payable	23.2	15.35	8.47	5.59	5.5	5.27	0.4	0.34
Deferred Revenue	6.81	8.34	0	0	0	0	0	0
Current Debt	4.17	1.05	0	0	0	0	0	0.05
Other Current Liabilities	9.77	2.98	7.53	4.9	2.84	2.66	0.49	0.5
Total Current Liabilities	43.94	27.72	16	10.49	8.34	7.93	0.9	0.89
Long-Term Debt	47.56	2.02	3.07	4.01	4.85	0	0	0.16
Other Long-Term Liabilities	4.75	6.1	0	0.02	0.05	3.27	0.02	17.75
Total Long-Term Liabilities	52.31	8.13	3.08	4.04	4.9	3.27	0.02	17.91
Total Liabilities	96.25	35.85	19.07	14.53	13.24	11.19	0.92	18.8
Total Debt	51.73	3.08	3.07	4.01	4.85	0	0	0.21
Debt Growth	1582.21%	0.03%	-23.42%	-17.22%	-	-	-	-
Retained Earnings	-653.7	-439.17	-275.26	-167.61	-93.8	-43.38	-16.27	-7.11
Comprehensive Income	0.98	-3.93	-0.38	0.03	0.15	0.06	0	0
Shareholders' Equity	539.11	316.33	331.94	168.92	117.14	160.23	-15.02	-6.2
Net Cash / Debt	508.13	332.65	331.13	167.37	114.04	164.38	14.19	11.94
Net Cash / Debt Growth	52.75%	0.46%	97.85%	46.76%	-30.62%	1058.22%	18.86%	-
Net Cash Per Share	8.75	6.40	8.62	5.50	4.72	13.54	10.35	11.81
Working Capital	530.21	317.46	328.73	167	115	158.76	14.27	11.48
Book Value Per Share	9.28	6.08	8.64	5.55	4.84	13.20	-10.96	-6.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).